Join the CME at Universal Studios Orlando from October 18th to 20th, 2024, for a unique educational experience combined with Halloween Nights festivities. Primary Care topics include the latest guidelines on opiate management, hypertension, evaluation of chest pain, skin and soft tissue infections, immunizations, STI treatment updates, cancer screening, and more. This event offers healthcare professionals an opportunity to earn continuing medical education credits while enjoying the attractions of Universal Studios and the Halloween-themed atmosphere. Don't miss out on this exciting opportunity to learn and have fun in one of the world's most renowned entertainment destinations.

 [Read on .a-crossmedicinereviews.com](https://www.a-crossmedicinereviews.com/universal-studios-orlando-october)

Explore a comprehensive range of topics crucial to primary care at our upcoming event. Join us from March 13th to March 16th, 2024, to delve into pain management, hypertension guidelines, diabetes mellitus management, cholesterol management, immunizations, and more. This conference welcomes professionals from various disciplines, including family practice, internal medicine, general practice, OB/GYN, subspecialists, nurse practitioners, and physician assistants. Don't miss this opportunity to stay updated on essential primary care practices and advancements.

Read on go.evvnt.com

Topics include latest hypertension guidelines, cancer screening, cholesterol management, immunizations, skin and soft tissue infections, COPD, etc. All topics germane to primary care! Family practice, internal medicine, general practice, OB/GYN, subspecialists, nurse practitioners, and physician assistants are welcome.

Read on go.evvnt.com

The conference aims to gather exceptional research and scientific advancements in the field of regenerative medicine. It provides a platform for networking, discussions, and collaboration opportunities. The event features renowned national and international researchers, oral presentations based on submitted abstracts, as well as exhibits and poster sessions. Join this conference to explore the latest breakthroughs and foster meaningful connections within the regenerative medicine community.

Read on go.evvnt.com

Topics include pain management, latest hypertension guidelines, diabetes mellitus management, cholesterol management, immunizations, etc. All topics germane to primary care! Family practice, internal medicine, general practice, OB/GYN, subspecialists, nurse practitioners, and physician assistants are welcome.

Read on go.evvnt.com

Topics include latest hypertension guidelines, cancer screening, cholesterol management, immunizations, skin and soft tissue infections, COPD, etc. All topics germane to primary care! Family practice, internal medicine, general practice, OB/GYN, subspecialists, nurse practitioners, and physician assistants are welcome.

Read on go.evvnt.com

The 42nd Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID) is set to occur from May 20 to May 24, 2024, in Tel Aviv. This distinguished global conference convenes professionals dedicated to advancing pediatric infectious diseases. With a meticulously designed scientific program, attendees can expect insights, collaborations, and captivating talks by esteemed experts, covering various areas of infectious diseases in children. The event remains committed to improving children's well-being worldwide, and its live-streaming option offers convenient access to high-quality CME education until March 10, 2024.

Read on go.evvnt.com

Topics include latest hypertension guidelines, cancer screening, cholesterol management, immunizations, skin and soft tissue infections, COPD, etc. All topics germane to primary care! Family practice, internal medicine, general practice, OB/GYN, subspecialists, nurse practitioners, and physician assistants are welcome. 

Read on go.evvnt.com

The 2023 conference will feature updates in gastroenterology, cardiology, neurology, hematology, infectious disease, nephrology, and more! This important CME conference will educate and promote improved patient outcomes in a broad range of therapeutic areas commonly encountered in the busy primary care practice. In addition to an overview of the history and current science of a variety of specialty areas, content will be presented in a very practical, patient-focused manner relevant to the specific primary care setting and challenges.

URL:

Tickets: https://go.evvnt.com/1280338-0?pid=10158

Prices:

Physicians (MD, DO, MBBS): USD 750.00,

RN, NP, PA, Others: USD 600.00,

Students, Residents, Fellows: USD 375.00

Speakers: Walter Coyle, MD, FACG, FACP - Scripps Clinic, Nancy Crum-Cianflone, MD, MPH, FACP, FIDSA - Avita Health System - Galion Hospital, Joel Diamant, MD, FACP - Scripps Clinic, Jack Schim, MD - The Neurology Center, KeAndrea Titer, MD - University of Alabama at Birmingham, Poulina Uddin, MD - Scripps Clinic, Karla Williams, MD - University of Alabama at Birmingham, Andrew King, MD - Scripps Clinic/Scripps Green Hospital

Date and Time: 27th March 2023 at 7:00 am to 30th March 2023 at 12:00 pm

With an improved understanding of biology and mechanisms of action, the Wnt/B-Catenin community is surging through clinic in 2022 with positive clinical updates. The excitement of a potential first-in-class candidate to advent combination, immuno-oncology therapies in colorectal, head and neck and non-small cell lung cancer is offering hope for patients with high unmet medical needs.

After 2 decades of research, it is now the time for drug developers to act and get together at the 2nd Wnt/B-Catenin Pathway Targeted Drug Development Summit. As the one and only industry-led meeting, you will be equipped with unparalleled insights in:

- Wnt/B-Catenin's structural biology and medicinal chemistry - turning the undruggable druggable

- Comparison of different Wnt/B-Catenin modulation approaches, its interaction with TIL and tumor microenvironment for targeted, combination therapies

- Translating basic science into clinical design - from scheduling to dosing, overcoming toxicity to widen the therapeutic window with safety in mind

- Validating a clinical biomarker for patient selection

In collaboration with Wnt/B-Catenin pioneers such as Iterion Therapeutics, Leap Therapeutics, FogPharma, this is your unique opportunity to join and meet 60+ drug developers to forge long-term collaboration and advance Wnt/B-Catenin as a valuable target and clinical asset, propelling to provide first-in-class treatments for patients!